Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical industry

Our New Policy Aims To Make Gujarat India's Defence Factory: CM Vijay Rupani

With 18% of India’s industrial output and 53% of the total FDI in 2020, Gujarat certainly stands tall among other federal States of India and its major economic indicators on right track. Debate is often on historic linkages but it is more about right policy, leadership, thrust on industry and governance. CM Dashboard is set up to monitor each projects underway across the States which is the first of its kind to check accountability--real time and digital. Gujarat's Chief Minister Vijay Rupani speaks with BW Businessworld's Manish Kumar Jha on such initiatives that make global investors flock to Gujarat. Beside industry and investment, he tells me more on Education, NEP and his plan for Green energy.

Read More

OPPI Elects S Sridhar As President

Sridhar is the Managing Director of Pfizer and is heading the company's commercial business in India

Read More

Union Budget 2021-22 Needs To Focus On Making India Healthy

Phytopharmaceuticals is another huge opportunity for the pharma industry in India. To ensure viability and growth of the industry, there needs to be serious thought and incentives should be provided.

Read More

Impact Of Covid-19 On Indian Economy

India’s ongoing GDP loses are likely to be approx $5-10 billion (0.15 - 0.35 percent of GDP), as per data. With more than 20% cut in benchmark indices; the Indian equity market has entered the bear market territory.

Read More

Not Without India: World's Pharmacy Gears Up For Vaccine Race

India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer Inc and Moderna shots, the nation will play a pivotal role in immunizing much of the world.

Read More

Industry Says $6 To $18 Per Dose Is Reasonable Price For COVID-19 Vaccine

A price between 5 and 15 euros a dose "is a reasonable price for a vaccine," Sue Middleton, President of the Executive Board, of Vaccines Europe told a hearing in the EU Parliament.

Read More

How Blockchain Is Vastly Improving Pharmaceutical Supply Chains And Delivering Safer Drugs

Countries like India and China specifically are very vulnerable to counterfeit products, as are several other Southeast Asian countries.

Read More

Combating COVID-19: PM Modi Tells Pharma Firms To Boost Production

The companies assured Prime Minister Modi that India has enough supplies of all essential pharma commodities and there is no reason to worry.

Read More

Pharma M&A Deals Touch $4.6 Billion In 2016

Indian players continued to look for access to under-penetrated markets and expand their product offerings

Read More

India Is Home To Largest 'Diabetes' Drugs Market Worldwide

Diabetes has been termed the 'Mother of all Diseases' and sadly despite of tremendous research by the medical industry, a permanent solution for it is yet to be found

Read More